Skip to main content

MDMA · Pharmala Biotech Holdings Inc. · Financials

0.15 CAD -0.015 (-9.09%) At close · Nov 6 Intraday price with Plus
Market Cap
16.53M CAD
Shares
110.18M
Volume · Nov 6 62.49K Avg daily vol (3M) 198.18K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
605.5K -41.5%
FY2025 Revenue FY2024–FY2025
Net Income
-2.18M -164.1%
FY2025 Net Income FY2024–FY2025
Gross Margin
91.22% +5.5pp
FY2025 Gross Margin FY2024–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024
CAD 605.5K 1.04M
CAD 552.34K 887.44K
CAD -2.18M -823.6K
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.